Rising incidences of genetic disorders that give rise to wide variety of
independent diagnostic procedures globally is predominantly driving the
growth of the global genetic disorder diagnostic market. Additionally,
increasing awareness about prenatal diagnosis, rising attempt to improve
patients quality of life and growing popularity of certain techniques
such as gene therapy, medical genetics are further expected to boost
market growth. Moreover, growing prevalence of genetic disorders such as
color blindness, Down’s syndrome, cystic fibrosis, etc. and frequent
incidences of disorder of synthesis of DNA, RNA & Protein are
factors that are also propelling the genetic disorder diagnosis market
growth. Expensive diagnosis and inadequate reimbursement procedures are
amongst few factors hindering market growth. However, advantages
associated with genetic disease diagnostics are expected to curb the
impact of aforementioned factors.
The global genetic disorder diagnosis market, by application is classified into inherited disorder testing, pharmacogenetic testing (PGx), human leukocyte antigen (HLA) testing, oncology testing, and others. Inherited disorder testing segment is further categories into Bbloom syndrome, Gaucher’s disease, Tay-Sachs disease, fragile x-syndrome and others. In 2014, oncology testing was one of the highest revenue generating application area. Key factors associated to its large share include growing pervasiveness of various kinds of cancer such as carcinoma & sarcoma, increasing tobacco and alcohol consumption among youth and detrimental lifestyle among significantly large young population such as improper diet, lack of exercise and increasing consumption of red meat etc. Furthermore, rising patient awareness pertaining to genetic disorders and its diagnostic techniques and rapid technological developments in its diagnostic techniques such as SBRT, robotic radio surgery and usage of molecular target agent are few factors that are further expected to boost oncology and consequently genetic disease diagnostics market over the forecast period. However, pharmacogenetic testing segment is expected to witness lucrative growth over the estimated period of seven years. Factors such as growing awareness regarding diagnosis and growing interest of healthcare professionals towards the genetic differences in the drug metabolic pathways are few factors attributing to the rapid growth of pharmacogenetic testing market over the forecast period.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/genetic-disease-diagnostic-market
Geographically, North America, Europe, Asia Pacific, MEA and Latin America regions are included in the study. In 2014, North America accounted for the majority of global genetic disease diagnosis market which is closely followed by Europe. Key factors attributing to its large share include the presence of developed healthcare infrastructure in the region, availability of skilled professionals & sophisticated genetic testing equipment, high healthcare expenditure and better reimbursement policies. However, Asia Pacific regional segment is expected to show a substantial growth rate over the forecast period. Constant development of medical tourism industry, rising healthcare expenditure, growing government initiatives pertaining to the development of healthcare infrastructure mainly biotechnology, agriculture and pharmacology are few factors which are contributing towards the rapid growth of Asia Pacific genetic disease diagnosis market.
About Grand View Research:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: www.grandviewresearch.com
The global genetic disorder diagnosis market, by application is classified into inherited disorder testing, pharmacogenetic testing (PGx), human leukocyte antigen (HLA) testing, oncology testing, and others. Inherited disorder testing segment is further categories into Bbloom syndrome, Gaucher’s disease, Tay-Sachs disease, fragile x-syndrome and others. In 2014, oncology testing was one of the highest revenue generating application area. Key factors associated to its large share include growing pervasiveness of various kinds of cancer such as carcinoma & sarcoma, increasing tobacco and alcohol consumption among youth and detrimental lifestyle among significantly large young population such as improper diet, lack of exercise and increasing consumption of red meat etc. Furthermore, rising patient awareness pertaining to genetic disorders and its diagnostic techniques and rapid technological developments in its diagnostic techniques such as SBRT, robotic radio surgery and usage of molecular target agent are few factors that are further expected to boost oncology and consequently genetic disease diagnostics market over the forecast period. However, pharmacogenetic testing segment is expected to witness lucrative growth over the estimated period of seven years. Factors such as growing awareness regarding diagnosis and growing interest of healthcare professionals towards the genetic differences in the drug metabolic pathways are few factors attributing to the rapid growth of pharmacogenetic testing market over the forecast period.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/genetic-disease-diagnostic-market
Geographically, North America, Europe, Asia Pacific, MEA and Latin America regions are included in the study. In 2014, North America accounted for the majority of global genetic disease diagnosis market which is closely followed by Europe. Key factors attributing to its large share include the presence of developed healthcare infrastructure in the region, availability of skilled professionals & sophisticated genetic testing equipment, high healthcare expenditure and better reimbursement policies. However, Asia Pacific regional segment is expected to show a substantial growth rate over the forecast period. Constant development of medical tourism industry, rising healthcare expenditure, growing government initiatives pertaining to the development of healthcare infrastructure mainly biotechnology, agriculture and pharmacology are few factors which are contributing towards the rapid growth of Asia Pacific genetic disease diagnosis market.
About Grand View Research:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: www.grandviewresearch.com
No comments:
Post a Comment